Teva Pharmaceutical Industries Ltd (TEVA) — Capital Reinvestment Ratio
Teva Pharmaceutical Industries Ltd (TEVA) has a Capital Reinvestment Ratio of 0.54x as of March 2026, meaning it reinvests 1% of its operating cash flow (ILA313.17 Million) in capital expenditures (ILA167.56 Million). See Teva Pharmaceutical Industries Ltd net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Teva Pharmaceutical Industries Ltd Capital Reinvestment Ratio (1991–2025)
This chart tracks Teva Pharmaceutical Industries Ltd's Capital Reinvestment Ratio across 34 annual periods. Check TEVA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Teva Pharmaceutical Industries Ltd (1991–2025)
Year-by-year Capital Reinvestment Ratio for Teva Pharmaceutical Industries Ltd from 1991 to 2025. For live market cap and broader valuation context, see TEVA market cap.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | ILA3.10 Billion | ILA542.32 Million | ▼ -56.2% |
| 2024 | 0.40x | ILA1.25 Billion | ILA498.00 Million | ▲ +3.9% |
| 2023 | 0.38x | ILA1.37 Billion | ILA526.00 Million | ▲ +11.6% |
| 2022 | 0.34x | ILA1.59 Billion | ILA548.00 Million | ▼ -51.1% |
| 2021 | 0.70x | ILA798.00 Million | ILA562.00 Million | ▲ +48.2% |
| 2020 | 0.48x | ILA1.22 Billion | ILA578.00 Million | ▲ +114.9% |
| 2019 | 0.22x | ILA538.00 Million | ILA119.00 Million | ▼ -16.9% |
| 2018 | 0.27x | ILA2.45 Billion | ILA651.00 Million | ▲ +6.8% |
| 2017 | 0.25x | ILA3.51 Billion | ILA874.00 Million | ▲ +44.5% |
| 2016 | 0.17x | ILA5.22 Billion | ILA901.00 Million | ▲ +23.8% |
| 2015 | 0.14x | ILA5.54 Billion | ILA772.00 Million | ▼ -23.1% |
| 2014 | 0.18x | ILA5.13 Billion | ILA929.00 Million | ▼ -43.1% |
| 2013 | 0.32x | ILA3.24 Billion | ILA1.03 Billion | ▲ +31.9% |
| 2012 | 0.24x | ILA4.57 Billion | ILA1.10 Billion | ▼ -5.2% |
| 2011 | 0.25x | ILA4.13 Billion | ILA1.05 Billion | ▲ +48.4% |
| 2010 | 0.17x | ILA4.14 Billion | ILA710.00 Million | ▼ -19.5% |
| 2009 | 0.21x | ILA3.37 Billion | ILA719.00 Million | ▲ +1.1% |
| 2008 | 0.21x | ILA3.23 Billion | ILA681.00 Million | ▼ -29.5% |
| 2007 | 0.30x | ILA1.81 Billion | ILA542.00 Million | ▲ +57.8% |
| 2006 | 0.19x | ILA2.06 Billion | ILA390.00 Million | ▼ -16.3% |
| 2005 | 0.23x | ILA1.37 Billion | ILA310.10 Million | ▼ -9.1% |
| 2004 | 0.25x | ILA1.25 Billion | ILA311.00 Million | ▼ -24.8% |
| 2003 | 0.33x | ILA626.60 Million | ILA207.50 Million | ▼ -27.0% |
| 2002 | 0.45x | ILA353.70 Million | ILA160.40 Million | ▼ -7.6% |
| 2001 | 0.49x | ILA273.15 Million | ILA134.07 Million | ▼ -9.1% |
| 2000 | 0.54x | ILA165.63 Million | ILA89.42 Million | ▲ +23.6% |
| 1999 | 0.44x | ILA153.61 Million | ILA67.07 Million | ▼ -77.4% |
| 1998 | 1.93x | ILA70.20 Million | ILA135.60 Million | ▲ +489.8% |
| 1997 | 0.33x | ILA193.60 Million | ILA63.40 Million | ▼ -69.3% |
| 1995 | 1.07x | ILA105.40 Million | ILA112.60 Million | ▼ -48.7% |
| 1994 | 2.08x | ILA38.20 Million | ILA79.50 Million | ▲ +73.2% |
| 1993 | 1.20x | ILA37.70 Million | ILA45.30 Million | ▲ +24.1% |
| 1992 | 0.97x | ILA28.20 Million | ILA27.30 Million | ▼ -60.5% |
| 1991 | 2.45x | ILA9.10 Million | ILA22.30 Million | — |